J3032 HCPCS code: Injection, eptinezumab-jjmr, 1 mg
J3032 is the HCPCS Level II code for injection, eptinezumab-jjmr, 1 mg. In 2024 Medicare paid an average of $13.94 per service for J3032 across 2,355,406 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 138% from 2022 to 2024 (991,105 to 2,355,406 services). In 2024, about 1,548 clinicians billed Medicare for J3032 for 3,804 beneficiaries; Florida, Texas, California accounted for 33% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-10-01 |
| Last action effective | 2020-10-01 |
Who bills J3032 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,548 |
| Medicare beneficiaries | 3,804 |
| States with claims | 37 |
| Share of services in top 3 states (Florida, Texas, California) | 33% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3032, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 991,105 | 2,045 | $15.52 | $12.36 |
| 2023 | 1,634,457 | 2,951 | $16.32 | $12.98 |
| 2024 | 2,355,406 | 3,804 | $17.51 | $13.94 |
States with the most J3032 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 328,101 | $14.17 |
| Texas | 233,012 | $13.89 |
| California | 209,009 | $14.23 |
| Georgia | 137,501 | $14.06 |
| New York | 123,503 | $13.17 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J3032
- 2020-10-01: J3032 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3032?
J3032 is the HCPCS Level II code for injection, eptinezumab-jjmr, 1 mg. Short descriptor: "Inj. eptinezumab-jjmr 1 mg".
How much does Medicare pay for J3032?
In 2024, the average Medicare payment was $13.94 per service (average allowed $17.51).
Does Medicare cover J3032?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3032 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J30 codes
- J3000 — Injection, streptomycin, up to 1 gm
- J3010 — Injection, fentanyl citrate, 0.1 mg
- J3030 — Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J3031 — Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3055 — Injection, talquetamab-tgvs, 0.25 mg
- J3060 — Injection, taliglucerase alfa, 10 units
- J3070 — Injection, pentazocine, 30 mg
- J3090 — Injection, tedizolid phosphate, 1 mg
- J3095 — Injection, telavancin, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3032
- Watch J3032 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3032
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.